Structure-functionality relationship of collagen-fibrin interpenetrating hydrogels for engineered tumor-stroma models
Source abstract
Abstract
Collagen and fibrin are two major extracellular matrix (ECM) proteins involved in tumorigenesis. During cancer progression, collagen and fibrin undergo sequential and concurrent polymerization and degradation, altering ECM structure and functional properties, which impact cell behavior and drug resistance. While engineered tumor models are recently emerging, including 3D printed tissue models and microphysiological systems (MPS), the interaction of these two proteins and its impact on the structure-functionality are largely overlooked. A critical knowledge gap on the structure-functionality relationship of collagen-fibrin interpenetrating hydrogels limits reliable reconstitution of the ECM of the tumor-stroma microenvironment. To address this, we characterized the fibrillar microstructure and biomechanical properties (e.g., diffusivity, Young's modulus, and cell-derived contraction) of collagen-fibrin interpenetrating hydrogels while varying the protein ratios and sequence of polymerization. The results show that the pore size of the composite matrices decreases as fibrin content increases. This structural change is correlated to the decreased diffusivity, which can be partially recovered after fibrin depletion. In contrast, Young's modulus only increases at lower fibrin content and decreases with increases in fibrin content, even below collagen-only levels. Cell-derived contraction is well correlated with these Young's modulus changes. Confocal microscopy analysis shows that collagen-fibrin gels have distinctly different microstructure depending on polymerization sequence, which highlights how collagen-fibrin interactions during polymerization shape matrix properties, with important implications for the design of engineered tumor models. STATEMENT OF SIGNIFICANCE: Engineered tumor models are emerging to recapitulate the complexity of human tumors with unprecedented cellular and molecular resemblance. Despite recent advancements, efforts to recreate the fibrin deposition caused by the extravascular coagulation due to leaky tumor vasculature is lacking. Furthermore, its impact on the structure-functionality relation of the tumor-stroma tissues poses a significant knowledge gap to reliably reconstitute biomaterials for engineered tumor models. To address this gap, we report how composition and polymerization conditions influence the microstructure and biomechanical properties of collagen-fibrin interpenetrating hydrogels. We show that both the collagen and fibrin concentration and polymerization sequence impact the interpenetrating microstructure and determine the diffusivity, Young's modulus, and contraction index of the hydrogel. These results are important by providing the quantitative knowledge-base for designing and analyzing biomaterials for new and innovative engineered tumor models.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Hydrogels: synthesis, properties, applications · Blood properties and coagulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (83)
Show source-provided references
1. Engineered in vitro tumor models for cell-based immunotherapy10.1016/j.actbio.2021.03.076 ↗
2. Recent advances on cell culture platforms for In vitro drug screening and cell therapies: from conventional to microfluidic strategies
3. Engineering of biomaterials for tumor modeling
4. Concepts of extracellular matrix remodelling in tumour progression and metastasis10.1038/s41467-020-18794-x ↗
5. Breaking through the barrier: modelling and exploiting the physical microenvironment to enhance drug transport and efficacy10.1016/j.addr.2022.114183 ↗
6. The role of extracellular matrix in biomechanics and its impact on bioengineering of cells and 3D tissues10.1016/j.matbio.2019.11.005 ↗
7. Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip10.1016/j.canlet.2015.12.003 ↗
8. Overcoming in vivo barriers to targeted nanodelivery10.1002/wnan.143 ↗
9. Cancer-associated fibroblasts: from basic science to anticancer therapy10.1038/s12276-023-01013-0 ↗
10. Tumors: wounds that do not heal-redux10.1158/2326-6066.CIR-14-0209 ↗
11. What does it take to make the perfect clot?10.1161/01.ATV.0000193624.28251.83 ↗
12. Fibrinolysis: an illustrated review
13. Fibrinolytic system and cancer: diagnostic and therapeutic applications10.3390/ijms22094358 ↗
14. Thrombin signaling promotes pancreatic adenocarcinoma through PAR-1-Dependent immune evasion10.1158/0008-5472.CAN-18-3206 ↗
15. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment10.1111/jth.15115 ↗
16. Inkjet-printed morphogenesis of tumor-stroma interface using bi-cellular bioinks of collagen-poly(N-isopropyl acrylamide-co-methyl methacrylate) mixture
17. A biomimetic tumor model of heterogeneous invasion in pancreatic ductal adenocarcinoma10.1002/smll.201905500 ↗
18. Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model10.1016/j.jconrel.2017.09.024 ↗
19. Bioprinting a novel glioblastoma tumor model using a fibrin-based bioink for drug screening10.1016/j.mtchem.2018.12.005 ↗
20. Microphysiologically engineered vessel-tumor model to investigate vascular transport dynamics of immune cells
21. The procoagulant signature of cancer cells drives fibrin network formation in tumor microenvironment and impacts its quality. Implications in cancer cell migration and the resistance to anticancer agents10.1016/j.thromres.2024.04.015 ↗
22. Fibrin binds to collagen and provides a bridge for alphaVbeta3 integrin-dependent contraction of collagen gels10.1042/BJ20140201 ↗
23. Pancreatic cancer stroma: an update on therapeutic targeting strategies10.1038/s41575-020-0300-1 ↗
24. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma10.1038/s41419-022-05351-1 ↗
25. Thermal destabilization of collagen matrix hierarchical structure by freeze/thaw10.1371/journal.pone.0146660 ↗
26. Spatiotemporal measurement of freezing-induced deformation of engineered tissues10.1115/1.4000875 ↗
27. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging10.1016/S0006-3495(93)81324-9 ↗
28. In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space10.1073/pnas.0509425103 ↗
29. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells10.1053/gast.2002.31885 ↗
30. Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity10.1186/1475-2867-5-1 ↗
31. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen10.1016/j.bpj.2012.10.036 ↗
32. Freezing-induced fluid-matrix interaction in poroelastic material10.1115/1.3005170 ↗
33. Pressure tunable adhesion of rough elastomers10.1039/D0SM01754J ↗
34. Designing interfacial reactions for nanometer-scale surface patterning of PDMS with controlled elastic modulus10.1021/acsami.2c22646 ↗
35. Size and density of fibrin fibers from turbidity10.1021/ma60061a009 ↗
36. Nanostructure of the fibrin clot10.1016/j.bpj.2010.04.059 ↗
37. Collagen hydrogel characterization: multi-scale and multi-modality approach10.1039/c0ay00381f ↗
38. Collagen density regulates the activity of tumor-infiltrating T cells10.1186/s40425-019-0556-6 ↗
39. Aggregates dramatically alter fibrin ultrastructure10.1016/j.bpj.2019.10.034 ↗
40. Thrombin generation and fibrin clot structure10.1016/j.blre.2006.11.001 ↗
41. Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells10.1182/blood.V95.10.3133 ↗
42. Extracellular fibrin promotes non-small cell lung cancer progression through integrin beta1/PTEN/AKT signaling
43. Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios10.1021/bm0602233 ↗
44. The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells10.1186/s13287-017-0764-2 ↗
45. Modulation of fibrin gel extracellular matrix properties by fibrinogen and thrombin concentrations for angiogenesis assay10.4028/www.scientific.net/AMR.911.342 ↗
46. Brain extracellular space as a diffusion barrier10.1007/s00791-012-0185-9 ↗
47. Abraxane, the nanoparticle formulation of Paclitaxel can induce drug resistance by up-regulation of P-gp10.1371/journal.pone.0131429 ↗
48. Tunable collagen I hydrogels for engineered physiological tissue micro-environments10.1371/journal.pone.0122500 ↗
49. Measurement of biomolecular diffusion in extracellular matrix condensed by fibroblasts using fluorescence correlation spectroscopy10.1371/journal.pone.0082382 ↗
50. Microstructural and mechanical differences between digested collagen-fibrin co-gels and pure collagen and fibrin gels10.1016/j.actbio.2012.07.010 ↗
51. A primer on cancer-associated fibroblast mechanics and immunosuppressive ability10.37349/etat.2023.00120 ↗
52. Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review10.1038/s41420-025-02566-x ↗
53. Cancer associated fibroblasts in cancer development and therapy10.1186/s13045-025-01688-0 ↗
54. Length of tandem repeats in fibrin's alphaC region correlates with fiber extensibility10.1111/j.1538-7836.2008.03147.x ↗
55. Nanomechanics of collagen microfibrils10.32098/mltj.01.2013.05 ↗
56. Transport of drugs from blood vessels to tumour tissue10.1038/nrc.2017.93 ↗
57. Type I collagen-fibrin mixed hydrogels: preparation, properties and biomedical applications10.3390/gels6040036 ↗
58. The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
59. Water retention capabilities of collagen, gelatin and peptide as studied by IR/QCM/RH system10.1016/j.saa.2020.118619 ↗
60. Collagen stiffness regulates cellular contraction and matrix remodeling gene expression10.1002/jbm.a.31423 ↗
61. Collagen matrix stiffness influencing on fibroblast contraction force10.3389/conf.FBIOE.2016.01.01917 ↗
62. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies10.1016/j.actbio.2022.08.005 ↗
63. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts10.1038/ncb2756 ↗
64. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy10.1186/s13045-022-01252-0 ↗
65. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer10.1186/s40164-025-00647-2 ↗
66. 2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells10.1163/156856208786052380 ↗
67. Promoting biological similarity by collagen microfibers in 3D colorectal cancer-stromal tissue: replicating mechanical properties and cancer stem cell markers10.1016/j.actbio.2024.07.001 ↗
68. Fibroblast-fibronectin patterning and network formation in 3D fibrin matrices10.1016/j.matbio.2017.06.001 ↗
69. The use of mixed collagen-Matrigel matrices of increasing complexity recapitulates the biphasic role of cell adhesion in cancer cell migration: ECM sensing, remodeling and forces at the leading edge of cancer invasion10.1371/journal.pone.0220019 ↗
70. Multiphoton excited polymerized biomimetic models of collagen fiber morphology to study single cell and collective migration dynamics in pancreatic cancer10.1016/j.actbio.2024.08.026 ↗
71. Dense collagen I as a biomimetic material to track matrix remodelling in renal carcinomas10.1021/acsomega.4c04442 ↗
72. Concepts of extracellular matrix remodelling in tumour progression and metastasis10.1038/s41467-020-18794-x ↗
73. The interplay between extracellular matrix remodeling and cancer therapeutics10.1158/2159-8290.CD-24-0002 ↗
74. EMT-related cell-matrix interactions are linked to states of cell unjamming in cancer spheroid invasion10.1016/j.isci.2024.111424 ↗
75. Durotaxis and extracellular matrix degradation promote the clustering of cancer cells10.1016/j.isci.2025.111883 ↗
76. Matrix confinement modulates 3D spheroid sorting and burst-like collective migration10.1016/j.actbio.2024.03.007 ↗
77. Physical constraints on accuracy and persistence during breast cancer cell chemotaxis10.1371/journal.pcbi.1006961 ↗
78. Combining two strategies to improve perfusion and drug delivery in solid tumors10.1073/pnas.1318415110 ↗
79. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments10.1186/s12943-023-01744-8 ↗
80. Physical traits of cancer10.1126/science.aaz0868 ↗
81. The blood-brain barrier in health and chronic neurodegenerative disorders10.1016/j.neuron.2008.01.003 ↗
82. Matrix stiffness-dependent microglia activation in response to inflammatory cues: in situ investigation by scanning electrochemical microscopy10.1039/D3SC03504B ↗
83. Engineering of a functional pancreatic acinus with reprogrammed cancer cells by induced PTF1a expression10.1039/D1LC00350J ↗